Chemistry:Bedoradrine
From HandWiki
Bedoradrine (INN; developmental code names KUR-1246, MN-221) is a sympathomimetic and bronchodilator medication that was developed for the treatment of preterm labor, asthma, and chronic obstructive pulmonary disease (COPD) but was never marketed.[1][2][3] It acts as an ultra-selective long-acting β2-adrenergic receptor agonist.[1][2] The drug was intended for intravenous administration.[1][2]
See also
References
- ↑ 1.0 1.1 1.2 "Bedoradrine for treating asthma and chronic obstructive pulmonary disease". Expert Opin Investig Drugs 23 (8): 1149–1156. August 2014. doi:10.1517/13543784.2014.928284. PMID 24938936.
- ↑ 2.0 2.1 2.2 "β(2) -adrenoceptor agonists: current and future direction". Br J Pharmacol 163 (1): 4–17. May 2011. doi:10.1111/j.1476-5381.2011.01216.x. PMID 21232045.
- ↑ "Bedoradrine: Uses, Interactions, Mechanism of Action". 18 November 2007. https://go.drugbank.com/drugs/DB05590.
Tocolytics/labor repressants (G02CA) | |
|---|---|
| β2 adrenoreceptor agonists | |
| Oxytocin antagonists | |
| NSAIDs | |
| Calcium channel blockers | |
| Myosin inhibitors | |
0.00 ![]() ![]() ![]() ![]() (0 votes) |
